Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitogen-activated protein kinase kinase kinase 9 (MAP3K9), also known as Mixed lineage kinase 1 (MLK1), is a serine/threonine-protein kinase belonging to the mixed-lineage kinase (MLK) family of the MAP3K superfamily. It acts as an essential upstream regulator of the c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) signaling pathways by phosphorylating and activating MAP2K4/MKK4 and MAP2K7/MKK7. MAP3K9 plays a critical role in regulating cellular responses to environmental stress, cell death, apoptosis, neuronal development, and cell proliferation. Dysregulation, overexpression, or mutations of MAP3K9 have been implicated in various cancers (such as prostate, pancreatic, and melanoma) and neurodegenerative disorders (such as Parkinson's and Alzheimer's diseases). Small molecule inhibitors targeting MAP3K9, such as CEP-1347 and URMC-099, have been investigated for their neuroprotective, anti-inflammatory, and anti-tumor properties. Although CEP-1347 showed promise in preclinical models, it failed to demonstrate clinical efficacy in Phase II/III trials for Parkinson's disease, highlighting the therapeutic challenges of targeting this pathway.
ATP-competitive kinase inhibition
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitogen-activated protein kinase kinase kinase 9 (MAP3K9).